Comment
doi: 10.1136/gut.2006.111872.
The role of Escherichia coli in inflammatory bowel disease
Affiliations
- PMID: 17440180
- PMCID: PMC1942130
- DOI: 10.1136/gut.2006.111872
Item in Clipboard
Comment
The role of Escherichia coli in inflammatory bowel disease
Gut.
2007 May.
Abstract
Mucosa‐associated E Coli are reported to be increased in Crohn's disease
Conflict of interest statement
Competing interests: JMR is a past/present member of advisory boards for Procter and Gamble, Schering‐Plough, Chiesi, Falk, and Celltech/UCB, and, with the University of Liverpool and Provexis UK, holds a patent for use of a soluble fibre preparation as maintenance therapy for Crohn's disease.
Comment on
-
High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease.Gut. 2007 May;56(5):669-75. doi: 10.1136/gut.2006.099796. Epub 2006 Oct 6. Gut. 2007. PMID: 17028128 Free PMC article.
Similar articles
-
The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.Adv Clin Exp Med. 2019 Jul;28(7):899-905. doi: 10.17219/acem/94149. Adv Clin Exp Med. 2019. PMID: 31066244
-
High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases.Int J Med Microbiol. 2011 Aug;301(6):475-9. doi: 10.1016/j.ijmm.2011.04.015. Epub 2011 May 26. Int J Med Microbiol. 2011. PMID: 21616711
-
Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.Curr Opin Gastroenterol. 2009 Jul;25(4):329-33. doi: 10.1097/MOG.0b013e32832b20bf. Curr Opin Gastroenterol. 2009. PMID: 19444096 Review.
-
[Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].MMW Fortschr Med. 1999 Dec 16;141(51-52):48-51. MMW Fortschr Med. 1999. PMID: 10949626 Review. German.
-
Role of the innate immune system in the pathogenesis of inflammatory bowel disease.J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):142-51. doi: 10.1097/MPG.0b013e3181821964. J Pediatr Gastroenterol Nutr. 2009. PMID: 19179875 Review.
Cited by
-
Propionate Induces Virulent Properties of Crohn's Disease-Associated Escherichia coli.Front Microbiol. 2020 Jul 8;11:1460. doi: 10.3389/fmicb.2020.01460. eCollection 2020. Front Microbiol. 2020. PMID: 32733408 Free PMC article.
-
Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach.Comput Struct Biotechnol J. 2021 Dec 2;19:6481-6489. doi: 10.1016/j.csbj.2021.11.037. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34938418 Free PMC article.
-
Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis.Gut Pathog. 2012 Dec 13;4(1):21. doi: 10.1186/1757-4749-4-21. Gut Pathog. 2012. PMID: 23234341 Free PMC article.
-
Traditional Herbal Medicine-Derived Sulforaphene LFS-01 Reverses Colitis in Mice by Selectively Altering the Gut Microbiota and Promoting Intestinal Gamma-Delta T Cells.Front Pharmacol. 2018 Jan 9;8:959. doi: 10.3389/fphar.2017.00959. eCollection 2017. Front Pharmacol. 2018. PMID: 29375374 Free PMC article.
-
Emodin modulates gut microbial community and triggers intestinal immunity.J Sci Food Agric. 2023 Feb;103(3):1273-1282. doi: 10.1002/jsfa.12221. Epub 2022 Sep 26. J Sci Food Agric. 2023. PMID: 36088620 Free PMC article.
References
-
- Subramanian S, Campbell B J, Rhodes J M. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis 200619475–484. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
